AGEN
Agenus Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.23
−0.12%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 10.62x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- 3.03x
- PEG TTM
- —
- Price / book
- -1.86x
- Price / sales
- 2.79x
- Price / cash flow
- -3.76x
Enterprise value
- Enterprise value
- $385.7M
- EV / sales
- 2.91x
- EV / EBITDA
- 2.48x
- EV / EBIT
- 10.66x
- Market cap
- $370.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026